Evonik at 2009 CPhI China
- Evonik at 2009 CPhI China- 23 -25 June, Shanghai. Evonik Booth No: E1E22-E1E23
- One of the world leaders in high performance pharmaceutical excipients and chemical catalysts
- Full range customer services
Evonik Industries is exhibiting its leading high performance pharmaceutical excipient and chemical catalyst product portfolio, with optimized full range customer services at this year’s CPhI China in Shanghai.
Drug releasing timer - EUDRAGIT®
The basis of our offering are our Poly(meth)acrylates for pharmaceutical applications. These polymers allow the active in the solid dosage form to perform during the passage of the human body. The flexibility to combine the different polymers enables you to achieve the desired drug release profile by releasing the drug at the right time and, if necessary, over a desired period of time. Other important functions are protection from external influences (moisture) or taste/odor masking to increase patient compliance.
It has been over half a century since the first EUDRAGIT® product was launched to the market. As the worldwide well-known trade mark in the industry, EUDRAGIT® product portfolio has been continuously developed over the years, and is used for various pharmaceutical applications. The range of our product portfolio provides full flexibility for the targeted drug release profiles by offering best performance for enteric, protective or sustained-release properties. Besides the products, Evonik’s Business Line Pharma Polymers also offers the related services include advanced technical support, formulation development, proof of concept, GMP services along the value chain of our customers.
High performance catalyst and full range customer services
Evonik’s precious metal powder catalysts are used in the synthesis of pharmaceuticals, fine chemicals and industrial chemicals, where performance criteria such as high selectivity, activity and filterability are demanded. As the worldwide leader in precious metal powder catalysts, Evonik currently has manufacturing facilities in Germany, Japan, Brazil and the US. A new production facility in Shanghai will start up in early 2010 and will utilize existing sales network to address its commitment of efficient services for local and international customers.
In addition, to optimize supply chain efficiency for its customers, Evonik also offers in China through its existing partnership with Heraeus (www.heraeus.com) the recycling of precious metals from spent catalysts. The comprehensive customer services help Evonik’s customers to generate more value in their processes.
Besides of the above products, Evonik is also exhibiting its Activated Base Metal Catalysts (ABMC), which are heterogeneous powder catalysts with no support (bulk catalysts) for slurry type reactions that are carried out in batch or semi-batch mode. They are very popular in the bulk chemicals, fine chemicals and pharmaceutical industry, though there are applications outside these industries.
Over the past 40 years, Evonik has gained broad expertise and know-how in chemical catalysts. Evonik is a leading supplier of catalytic system solutions. It offers an extensive range of heterogeneous and certain homogeneous catalysts in a single source, as well as integrated services for customers in the life sciences, fine chemicals, industrial chemicals, chemical intermediates, and polymers industries.
For more information about our chemicals catalysts, welcome to visit www.evonik.com/catalysts.
Evonik Industries is the creative industrial group from Germany which operates in three business areas: Chemicals, Energy and Real Estate. Evonik is a global leader in specialty chemicals, an expert in power generation from hard coal and renewable energies, and one of the largest private residential real estate companies in Germany. Our strengths are creativity, specialization, continuous self-renewal, and reliability. Evonik is active in over 100 countries around the world. In its fiscal year 2008 about 41,000 employees generated sales of about €15.9 billion and an operating profit (EBITDA) of about €2.2 billion.
Evonik Industries has been producing specialty chemical products in China since the early 1990’s, with wide-ranging trading relations already in place p
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.